|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Low-dose mifepristone for contraception: a weekly versus planned postcoital |
| Godfrey EM; Mawson JT; Stanwood NL; Fielding SL; Schaff EA |
| Contraception. 2004 Jul;70(1):41-46. |
| In this randomized pilot study, we compared the contraceptive efficacy, safety and side effect profiles of weekly |
| versus planned postcoital regimens of low-dose mifepristone. Forty participants were randomized to receive |
| mifepristone 10 mg weekly or planned postcoitally (to be used no more frequently than once every 5 days), for 12 |
| consecutive months. Participants were evaluated monthly to determine pregnancy, ovulation status and acceptability |
| of physical side effects. We ended this pilot study prematurely due to low efficacy and predetermined stopping rules. |
| Three pregnancies during 56 woman-months occurred in the weekly group and three pregnancies during 68 woman- |
| months occurred in the planned postcoital group. Almost half of the participants ovulated monthly on either regimen. |
| The majority of the participants found the physical side effects of these regimens acceptable. Participants in the |
| planned postcoital group, however, found adhering to the regimen more difficult than those in the weekly group. |
| Mifepristone 10 mg used weekly or planned postcoitally did not adequately prevent pregnancy in our pilot study |
| population. Although the concept of intermittent low-dose mifepristone is appealing, the contraceptive effectiveness |
| was disappointing. (PubHealth.info Document ID: CONT1T 580-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Low-dose mifepristone for contraception: a weekly versus |
| planned postcoital randomized pilot study.", is(are) Godfrey EM; Mawson JT; Stanwood NL; Fielding SL; Schaff |
| EA. The source of this article is "Contraception. 2004 Jul;70(1):41-46.". This article was published in 2004 in |
| English language(s). (PubHealth.info® Document ID: CONT1T 580-06. All rights reserved with PubHealth.info) PIN: |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |